Developer docs
API playgroundTry for free, no card

Search company profiles

Oxitone Medical

Full company profile

uuid0003n86

Namestring
Oxitone Medical
Legal namestring
Oxitone Medical Ltd.
Websiteurl
oxitone.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Oxitone Medical Ltd. is an Israel-based medtech and digital health company developing a wrist-worn, FDA-cleared continuous patient monitoring platform. Its proprietary FlexSense technology places multi-parameter medical biosensors against the ulna bone, capturing SpO2, pulse rate, heart rate variability, respiratory rate, skin temperature, sleep, activity, and (in the 2000M generation) cuffless blood pressure. Two hardware generations anchor the product line: the Oxitone 1000M, the first FDA 510(k)-cleared wrist-sensor pulse oximeter (mass production launched January 2020), and the next-generation Oxitone 2000M, which adds continuous cuffless blood pressure measurement. Device data is routed via Bluetooth Low Energy or API into the Oxitone cloud platform, which provides physician dashboards, clinical reports, smart notifications, and an AI-enabled Medical Intelligence module for baseline anomaly detection, exacerbation prediction, and automated patient follow-up. The company's stated AI follow-up capability carries a U.S. regulatory caveat, which is a meaningful commercialization constraint in its primary market.

The business model combines medical device hardware sales (Oxitone 1000M and 2000M) with a recurring SaaS platform subscription (Oxitone Integrated SaaS / Clinical Portal) and professional services for implementation and clinical support. Pricing is not publicly disclosed and is quote-based through an enterprise "Request a Demo" funnel, consistent with a consultative field-sales motion. Oxitone targets three primary customer segments: healthcare providers (hospitals, health systems, nursing homes, physician practices managing high-risk chronic patients), payers (insurance companies seeking risk stratification and care management), and pharma/CRO organizations (clinical trial endpoint data and post-market surveillance). Distribution is direct enterprise sales supported by US (Hartford, CT) and Israel (Kfar Saba) offices, complemented by OEM/embedded integrations with healthcare-IT vendors such as Ascom (Digistat Wearables). Named reference customers are limited (Baptist Health in Louisville and the Ascom channel), and total disclosed funding across five rounds since 2010 is approximately $10.5 million, with the most recent raise a $1 million round in September 2020 led by Telcom Ventures. Leadership comprises CEO and co-founder Ofer Harpak, founder and executive chairman Dr. Leon Eisen, and COO/CFO Morris Azulay.

Short descriptiontext

Oxitone Medical is an Israel-based medtech company that builds FDA-cleared wrist-worn biosensors (Oxitone 1000M and 2000M) and a cloud SaaS platform for continuous remote monitoring of high-risk chronic patients, serving healthcare providers, payers, and pharma/CRO customers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersKfar Saba, Israel
HQ citystring
Kfar Saba
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
remote patient monitoring, medical biosensors, continuous vital signs, AI healthcare analytics, wearable medical devices
Industry2 codes
PRIMARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Remote Patient Monitoring Medical Devices
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Device Hardware Sales
TypeHardware Sales
Description

Sale of FDA-cleared wrist-worn medical monitoring devices including Oxitone 1000M (first FDA-cleared wrist-sensor pulse oximeter) and Oxitone 2000M (cuffless blood pressure monitor). Devices are sold to healthcare providers, payers, and directly to patients.

oxitone.com
2SaaS/Cloud Platform Subscription
TypeSubscription Recurring
Description

Subscription-based access to Oxitone cloud platform with integrated SaaS portal, clinical dashboards, data analytics, and medical intelligence tools. Includes API integration capabilities for enterprise customers.

oxitone.com
3Professional Services
TypeProfessional Services
Description

Implementation and support services for healthcare providers, payers, and pharma/CRO organizations including training, integration, and ongoing clinical support.

oxitone.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Oxitone Medical designs and sells FDA-cleared wrist-worn medical biosensors (Oxitone 1000M and Oxitone 2000M) that continuously monitor blood oxygen, pulse rate, HRV, respiratory rate, blood pressure, and other vital signs. The devices are paired with a cloud-based SaaS platform that provides AI-driven predictive analytics, physician dashboards, and API/Bluetooth integration for healthcare providers, payers, and pharmaceutical/CRO customers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Zero COVID-19 patient readmissions at Baptist Health using continuous monitoring
+4 more records
Product overview1 text field

Oxitone Medical offers a unified Digital Continuous Care platform centered on wearable medical devices and cloud-based analytics. The core product portfolio includes two generations of FDA-cleared wrist-worn biosensors (Oxitone 1000M and Oxitone 2000M) that provide continuous monitoring of blood oxygen, pulse rate, HRV, respiratory rate, and other vital signs. These devices are complemented by the Oxitone Integrated SaaS Platform, which provides the cloud infrastructure, physician portals, dashboards, and data analytics tools for comprehensive patient monitoring. The Oxitone Medical Intelligence module adds AI-powered predictive analytics and automated patient follow-up capabilities. Together, these products form an end-to-end continuous remote patient monitoring (CRPM) solution designed for high-risk chronic patients, enabling real-time health data collection, AI-powered anomaly detection and prediction, and automated clinical workflows for providers, payers, and pharma/CRO organizations.

Product and service3 records
1Oxitone 2000M
CategoryMedical Device Hardware
Description

Next-generation FDA-cleared wrist-worn medical monitor providing continuous cuffless blood pressure measurement (systolic and diastolic), cardiac monitoring (pulse rate, HRV, cardiac output), respiratory monitoring (SpO2, respiratory rate), and wellness tracking (skin temperature, sleep, activity, dehydration). Sold to healthcare providers, payers, and pharma/CRO customers for continuous patient monitoring.

2Oxitone 1000M
CategoryMedical Device Hardware
Description

First FDA 510(k)-cleared wrist-sensor pulse oximetry monitor for continuous patient monitoring. The wrist-worn device continuously monitors pulse rate, Heart Rate Variability (HRV), blood oxygen saturation (SpO2), respiratory rate, skin temperature, sleep patterns, and activity. Features FlexSense technology that embraces the ulna bone for medical-grade accuracy and enhanced comfort.

3Oxitone Integrated SaaS Platform
CategoryCloud SaaS Platform
Description

Full end-to-end patient monitoring software platform including physician web portal and dashboards, secured cloud infrastructure, data analytics tools, clinical reports, API integration tools, and on-demand data delivery. Supports multi-parameter patient monitoring across providers, payers, and pharma/CRO clients with Bluetooth Low Energy device integration.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2020-07-05
Description

Ascom UMS selected Oxitone Medical for continuous monitoring of COVID-19 patients through integration of the Oxitone 1000M into the Digistat® Wearables solution. This integration enriches information collected from wearable devices, enabling significant enhancement of patient monitoring capabilities.

Strategic tierMinorTypeOthers
Description

Listed as a key player in the North America AI Diagnostics Market alongside Oxitone Medical. Both companies leverage AI to enhance diagnostic accuracy and efficiency across hospitals, research laboratories, and contract research organizations.

Strategic tierMinorTypeOthers
Description

Listed as a key player in the North America AI Diagnostics Market alongside Oxitone Medical. Both companies leverage AI to enhance diagnostic accuracy and efficiency across hospitals, research laboratories, and contract research organizations.

Strategic tierMinorTypeOthers
Description

Listed as a key player in the North America AI Diagnostics Market alongside Oxitone Medical. Both companies leverage AI to enhance diagnostic accuracy and efficiency across hospitals, research laboratories, and contract research organizations.

Strategic tierMinorTypeGTM or Marketing Partner
Description

StartUp Health featured Oxitone 1000M in their Tech Product Watch series, highlighting how Oxitone's wrist-worn continuous pulse oximeter brings the hospital into the home and replaces bulky fingertip devices.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Masimo is the dominant global manufacturer of pulse oximetry and patient-monitoring technologies. It directly competes with Oxitone in clinical-grade SpO2 and continuous vital-signs monitoring, especially in the hospital and post-acute settings where Oxitone markets its wrist-sensor oximeter.

TypeDirect peer
Description

iRhythm offers the Zio wearable for continuous cardiac arrhythmia monitoring with cloud-based analytics. It is comparable to Oxitone as a wearable, FDA-cleared, AI-driven continuous-monitoring device company selling into the same provider/payer ecosystem for chronic cardiac patients.

TypeDirect peer
Description

Nonin is a long-established pulse oximetry and capnography device manufacturer. It is comparable as a direct competitor in SpO2 and vital-signs monitoring hardware, particularly for fingertip and wearable form factors used in clinical and remote-patient-monitoring applications.

TypeDirect peer
Description

Vivify Health provides a remote patient monitoring SaaS platform with connected device integration for chronic disease management. It is comparable as a SaaS-based RPM platform sold to providers and payers, addressing many of the same chronic-care and post-acute use cases Oxitone targets.

TypeDirect peer
Description

Current Health (Best Buy Health) offers an FDA-cleared continuous vital-signs monitoring platform combining a wearable device with AI-powered analytics and provider dashboards. It directly mirrors Oxitone's hardware-plus-SaaS model targeting high-risk chronic and post-acute patient populations.

TypeEmerging player
Description

Biobeat is an Israeli wearable RPM company offering cuffless BP and multi-parameter vital-signs monitoring patches and wrist devices. It is a closely comparable emerging competitor with similar cuffless-BP positioning, overlapping geographies (Israel origin), and overlapping customer segments.

TypeBroad incumbent
Description

Preventice, acquired by Boston Scientific, offers BodyGuardian wearable cardiac RPM with cloud analytics. It is comparable as a continuously-worn, FDA-cleared vital-signs monitor sold into the same provider remote-monitoring workflows Oxitone addresses, now backed by a major medtech incumbent.

TypeBroad incumbent
Description

Medtronic is a broad medical-device incumbent offering continuous cardiac and patient monitoring solutions (LINQ, VitalConnect partnerships, Patient Monitoring). It overlaps with Oxitone across hospital and remote cardiac/vital-signs monitoring and was named alongside Oxitone in AI diagnostics market coverage.

TypeBroad incumbent
Description

GE Healthcare is a global incumbent in hospital patient monitoring (CARESCAPE) and AI-enabled diagnostics. It overlaps Oxitone on continuous vital-signs monitoring for in-hospital and ambulatory patients and was named alongside Oxitone in AI diagnostics market landscape reports.

TypeBroad incumbent
Description

Omron is the dominant consumer and clinical blood pressure monitor brand globally with expanding connected/wireless BP devices. It is comparable to Oxitone's Oxitone 2000M cuffless BP offering as a competitor in the ambulatory BP monitoring market with strong brand and distribution.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Oxitone Medical

Remote Patient Monitoring Medical Devicesoxitone.com

Oxitone Medical is an Israel-based medtech company that builds FDA-cleared wrist-worn biosensors (Oxitone 1000M and 2000M) and a cloud SaaS platform for continuous remote monitoring of high-risk chronic patients, serving healthcare providers, payers, and pharma/CRO customers.

What Oxitone Medical does

Oxitone Medical Ltd. is an Israel-based medtech and digital health company developing a wrist-worn, FDA-cleared continuous patient monitoring platform. Its proprietary FlexSense technology places multi-parameter medical biosensors against the ulna bone, capturing SpO2, pulse rate, heart rate variability, respiratory rate, skin temperature, sleep, activity, and (in the 2000M generation) cuffless blood pressure. Two hardware generations anchor the product line: the Oxitone 1000M, the first FDA 510(k)-cleared wrist-sensor pulse oximeter (mass production launched January 2020), and the next-generation Oxitone 2000M, which adds continuous cuffless blood pressure measurement. Device data is routed via Bluetooth Low Energy or API into the Oxitone cloud platform, which provides physician dashboards, clinical reports, smart notifications, and an AI-enabled Medical Intelligence module for baseline anomaly detection, exacerbation prediction, and automated patient follow-up. The company's stated AI follow-up capability carries a U.S. regulatory caveat, which is a meaningful commercialization constraint in its primary market.

The business model combines medical device hardware sales (Oxitone 1000M and 2000M) with a recurring SaaS platform subscription (Oxitone Integrated SaaS / Clinical Portal) and professional services for implementation and clinical support. Pricing is not publicly disclosed and is quote-based through an enterprise "Request a Demo" funnel, consistent with a consultative field-sales motion. Oxitone targets three primary customer segments: healthcare providers (hospitals, health systems, nursing homes, physician practices managing high-risk chronic patients), payers (insurance companies seeking risk stratification and care management), and pharma/CRO organizations (clinical trial endpoint data and post-market surveillance). Distribution is direct enterprise sales supported by US (Hartford, CT) and Israel (Kfar Saba) offices, complemented by OEM/embedded integrations with healthcare-IT vendors such as Ascom (Digistat Wearables). Named reference customers are limited (Baptist Health in Louisville and the Ascom channel), and total disclosed funding across five rounds since 2010 is approximately $10.5 million, with the most recent raise a $1 million round in September 2020 led by Telcom Ventures. Leadership comprises CEO and co-founder Ofer Harpak, founder and executive chairman Dr. Leon Eisen, and COO/CFO Morris Azulay.

Oxitone Medical firmographics

Firmographics
Name
Oxitone Medical
Legal name
Oxitone Medical Ltd.
Website
https://oxitone.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
1–10 employees
Short description
Oxitone Medical is an Israel-based medtech company that builds FDA-cleared wrist-worn biosensors (Oxitone 1000M and 2000M) and a cloud SaaS platform for continuous remote monitoring of high-risk chronic patients, serving healthcare providers, payers, and pharma/CRO customers.
Ownership category
akta.pro rank

Oxitone Medical industry classification

Industry
Product category
Remote Patient Monitoring Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

Keywords

  • Remote patient monitoring
  • Medical biosensors
  • Continuous vital signs
  • AI healthcare analytics
  • Wearable medical devices

Where Oxitone Medical is headquartered

Location

Headquarters

HQ city
Kfar Saba
HQ country
Israel
HQ region
Middle East

Offices2 records

Markets served

Oxitone Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Device Hardware Sales: Sale of FDA-cleared wrist-worn medical monitoring devices including Oxitone 1000M (first FDA-cleared wrist-sensor pulse oximeter) and Oxitone 2000M (cuffless blood pressure monitor). Devices are sold to healthcare providers, payers, and directly to patients.
  2. SaaS/Cloud Platform Subscription: Subscription-based access to Oxitone cloud platform with integrated SaaS portal, clinical dashboards, data analytics, and medical intelligence tools. Includes API integration capabilities for enterprise customers.
  3. Professional Services: Implementation and support services for healthcare providers, payers, and pharma/CRO organizations including training, integration, and ongoing clinical support.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Oxitone Medical product offering

Product offering

Core offering

Oxitone Medical designs and sells FDA-cleared wrist-worn medical biosensors (Oxitone 1000M and Oxitone 2000M) that continuously monitor blood oxygen, pulse rate, HRV, respiratory rate, blood pressure, and other vital signs. The devices are paired with a cloud-based SaaS platform that provides AI-driven predictive analytics, physician dashboards, and API/Bluetooth integration for healthcare providers, payers, and pharmaceutical/CRO customers.

Product overview

Oxitone Medical offers a unified Digital Continuous Care platform centered on wearable medical devices and cloud-based analytics. The core product portfolio includes two generations of FDA-cleared wrist-worn biosensors (Oxitone 1000M and Oxitone 2000M) that provide continuous monitoring of blood oxygen, pulse rate, HRV, respiratory rate, and other vital signs. These devices are complemented by the Oxitone Integrated SaaS Platform, which provides the cloud infrastructure, physician portals, dashboards, and data analytics tools for comprehensive patient monitoring. The Oxitone Medical Intelligence module adds AI-powered predictive analytics and automated patient follow-up capabilities. Together, these products form an end-to-end continuous remote patient monitoring (CRPM) solution designed for high-risk chronic patients, enabling real-time health data collection, AI-powered anomaly detection and prediction, and automated clinical workflows for providers, payers, and pharma/CRO organizations.

Differentiator

Problem solved

Functional benefit

Products and services

  • Oxitone 2000M Next-generation FDA-cleared wrist-worn medical monitor providing continuous cuffless blood pressure measurement (systolic and diastolic), cardiac monitoring (pulse rate, HRV, cardiac output), respiratory monitoring (SpO2, respiratory rate), and wellness tracking (skin temperature, sleep, activity, dehydration). Sold to healthcare providers, payers, and pharma/CRO customers for continuous patient monitoring.
  • Oxitone 1000M First FDA 510(k)-cleared wrist-sensor pulse oximetry monitor for continuous patient monitoring. The wrist-worn device continuously monitors pulse rate, Heart Rate Variability (HRV), blood oxygen saturation (SpO2), respiratory rate, skin temperature, sleep patterns, and activity. Features FlexSense technology that embraces the ulna bone for medical-grade accuracy and enhanced comfort.
  • Oxitone Integrated SaaS Platform Full end-to-end patient monitoring software platform including physician web portal and dashboards, secured cloud infrastructure, data analytics tools, clinical reports, API integration tools, and on-demand data delivery. Supports multi-parameter patient monitoring across providers, payers, and pharma/CRO clients with Bluetooth Low Energy device integration.

Quantifiable outcome

  • Zero COVID-19 patient readmissions at Baptist Health using continuous monitoring
  • +4 more outcomes

Companies that use Oxitone Medical

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Oxitone Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability4 records

Feature4 records

Oxitone Medical partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Ascom UMScoreTechnology or Integration · 5 July 2020Ascom UMS selected Oxitone Medical for continuous monitoring of COVID-19 patients through integration of the Oxitone 1000M into the Digistat® Wearables solution. This integration enriches information collected from wearable devices, enabling significant enhancement of patient monitoring capabilities.
  • MedtronicminorOthersListed as a key player in the North America AI Diagnostics Market alongside Oxitone Medical. Both companies leverage AI to enhance diagnostic accuracy and efficiency across hospitals, research laboratories, and contract research organizations.
  • Siemens HealthineersminorOthersListed as a key player in the North America AI Diagnostics Market alongside Oxitone Medical. Both companies leverage AI to enhance diagnostic accuracy and efficiency across hospitals, research laboratories, and contract research organizations.
  • MC10minorOthersListed as a key player in the North America AI Diagnostics Market alongside Oxitone Medical. Both companies leverage AI to enhance diagnostic accuracy and efficiency across hospitals, research laboratories, and contract research organizations.
  • StartUp HealthminorGTM or Marketing PartnerStartUp Health featured Oxitone 1000M in their Tech Product Watch series, highlighting how Oxitone's wrist-worn continuous pulse oximeter brings the hospital into the home and replaces bulky fingertip devices.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Oxitone Medical competitors and assessment

Company assessment

Direct peers

  • Masimo: Masimo is the dominant global manufacturer of pulse oximetry and patient-monitoring technologies. It directly competes with Oxitone in clinical-grade SpO2 and continuous vital-signs monitoring, especially in the hospital and post-acute settings where Oxitone markets its wrist-sensor oximeter.
  • iRhythm Technologies: iRhythm offers the Zio wearable for continuous cardiac arrhythmia monitoring with cloud-based analytics. It is comparable to Oxitone as a wearable, FDA-cleared, AI-driven continuous-monitoring device company selling into the same provider/payer ecosystem for chronic cardiac patients.
  • Nonin Medical: Nonin is a long-established pulse oximetry and capnography device manufacturer. It is comparable as a direct competitor in SpO2 and vital-signs monitoring hardware, particularly for fingertip and wearable form factors used in clinical and remote-patient-monitoring applications.
  • Vivify Health: Vivify Health provides a remote patient monitoring SaaS platform with connected device integration for chronic disease management. It is comparable as a SaaS-based RPM platform sold to providers and payers, addressing many of the same chronic-care and post-acute use cases Oxitone targets.
  • Current Health: Current Health (Best Buy Health) offers an FDA-cleared continuous vital-signs monitoring platform combining a wearable device with AI-powered analytics and provider dashboards. It directly mirrors Oxitone's hardware-plus-SaaS model targeting high-risk chronic and post-acute patient populations.

Emerging players

  • Biobeat: Biobeat is an Israeli wearable RPM company offering cuffless BP and multi-parameter vital-signs monitoring patches and wrist devices. It is a closely comparable emerging competitor with similar cuffless-BP positioning, overlapping geographies (Israel origin), and overlapping customer segments.

Broad incumbents

  • Preventice Solutions (Boston Scientific): Preventice, acquired by Boston Scientific, offers BodyGuardian wearable cardiac RPM with cloud analytics. It is comparable as a continuously-worn, FDA-cleared vital-signs monitor sold into the same provider remote-monitoring workflows Oxitone addresses, now backed by a major medtech incumbent.
  • Medtronic: Medtronic is a broad medical-device incumbent offering continuous cardiac and patient monitoring solutions (LINQ, VitalConnect partnerships, Patient Monitoring). It overlaps with Oxitone across hospital and remote cardiac/vital-signs monitoring and was named alongside Oxitone in AI diagnostics market coverage.
  • GE Healthcare: GE Healthcare is a global incumbent in hospital patient monitoring (CARESCAPE) and AI-enabled diagnostics. It overlaps Oxitone on continuous vital-signs monitoring for in-hospital and ambulatory patients and was named alongside Oxitone in AI diagnostics market landscape reports.
  • Omron Healthcare: Omron is the dominant consumer and clinical blood pressure monitor brand globally with expanding connected/wireless BP devices. It is comparable to Oxitone's Oxitone 2000M cuffless BP offering as a competitor in the ambulatory BP monitoring market with strong brand and distribution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Oxitone Medical social profiles

Digital presence

Oxitone Medical compliance and trust

Trust signal

Compliance1 record

Oxitone Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Oxitone Medical leadership team

Management profile

Number of profiles

Profiles3 records

Oxitone Medical funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Oxitone Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oxitone Medical

What does Oxitone Medical do?

Oxitone Medical designs and sells FDA-cleared wrist-worn medical biosensors (Oxitone 1000M and Oxitone 2000M) that continuously monitor blood oxygen, pulse rate, HRV, respiratory rate, blood pressure, and other vital signs. The devices are paired with a cloud-based SaaS platform that provides AI-driven predictive analytics, physician dashboards, and API/Bluetooth integration for healthcare providers, payers, and pharmaceutical/CRO customers.

Is Oxitone Medical a public or private company?

Oxitone Medical is a private company. It is classified as venture growth investor backed and is currently operating.

When was Oxitone Medical founded?

Oxitone Medical was founded in 2019. It employs 1 to 10 people.

Where is Oxitone Medical based?

Oxitone Medical is headquartered in Kfar Saba, Israel, in the Middle East region.

How does Oxitone Medical make money?

Three revenue lines are on record. Medical Device Hardware Sales are the primary driver. The others are saaS/Cloud Platform Subscription and professional Services.

Who are Oxitone Medical's main competitors?

Direct peers on record are Masimo, iRhythm Technologies, Nonin Medical, Vivify Health and Current Health. Biobeat is listed as an emerging player. Broad incumbents are Preventice Solutions (Boston Scientific), Medtronic, GE Healthcare and Omron Healthcare.

Does Oxitone Medical have an API?

Yes. Oxitone offers API integration for transferring patient data to external platforms. Customers can integrate the Oxitone cloud platform into their platform via secure API. The Oxitone platform provides API integration tools for data delivery on demand. Oxitone also supports direct integration of the Oxitone 1000M device into their platform via Bluetooth Low Energy. Developer documentation is at www.oxitone.com/integrated-saas.

What industry is Oxitone Medical in?

Oxitone Medical's product category is Remote Patient Monitoring Medical Devices. Its primary akta.pro industry code is HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
LinkedInNorth America AI Diagnostics Market Trend Analysis Highlights Rapid Growth with a Projected CAGR of 5.3% from 2026 to 2033The North America AI Diagnostics Market is experiencing significant growth, driven by advancements in healthcare technology, increasing demand for personalized medicine, and rising chronic disease prevalence, with a projected compound annual growth rate (CAGR) of 5.3% from 2026 to 2033. Key trends include the integration of machine learning and deep learning technologies in diagnostic tools, telemedicine expansion, and increased collaborations between tech firms and healthcare providers. The United States leads the market, followed by Canada, while key players such as Medtronic, Siemens Healthineers, Oxitone Medical, and MC10 are leveraging AI to enhance diagnostic accuracy and efficiency across hospitals, research laboratories, and contract research organizations.PR NewswireAscom UMS Selected Oxitone Medical as a Wearable Solution for Continuous Remote Monitoring of COVID-19 PatientsAscom UMS has selected Oxitone Medical’s wrist-sensor pulse oximetry monitor as a wearable solution for the continuous remote monitoring of COVID-19 patients. The Oxitone 1000M device has been integrated into Ascom's Digistat® Wearables system to enhance remote care workflows and identify decompensating patients, including those with silent hypoxia. This partnership aims to optimize the measurement and recording of vital signs for patients not requiring hospitalization.PR NewswireDevice Connectivity Set to Drive Major Care Change for Millions of COPD PatientsABI Research published market forecasts indicating that wearable device connectivity for chronic respiratory diseases will drive shipments from three million in 2017 to 12 million by 2022, with the U.S. projected to lead spending at $6 million of a $21 million global market. The report highlights a shift from wireless finger-clip devices to wrist-worn wearables that continuously monitor oxygen levels and pulse rates, citing products from Nonin Medical and Oxitone Medical as examples of emerging solutions. Regulatory compliance remains a key challenge as manufacturers must navigate medical standards early in the product design phase.MedCity NewsDevice moves continuous oxygen saturation monitoring from the fingertip to the wristOxitone Medical is developing a wrist-worn device to continuously monitor heart rate and oxygen saturation, targeting COPD and heart failure patients. The prototype tested within ±3% of FDA requirements, and the company plans to raise $3 million for FDA clearance and a 2015 market launch at about $200.TimesofisraelThe Israeli medical device Steve Jobs would have likedOxitone, an Israeli company, was selected for GE Healthcare's Start-Up Health Academy program, a three-year initiative. Its wrist-based blood-oxygen monitor aims to provide continuous monitoring for COPD patients, addressing the pain and infrequency of traditional finger oximeters. The company's CEO suggested the device might have appealed to Steve Jobs, who reportedly disliked finger oximeters.TimesofisraelStartup success depends on who’s calling the shots, says entrepreneurDr. Leon Eisen argues that most startups fail due to incompetence and an overreliance on MBAs, who lack hands-on experience. He cites a medical device example where hospitals prioritize profit over patient days, and warns that hiring MBAs for due diligence often leads to market misjudgment.